Close Menu

NEW YORK (GenomeWeb) – Fluidigm reported after the close of the market on Thursday that its first quarter revenues grew 19 percent year over year on strong demand for the company's Helios and Hyperion imaging mass cytometry systems.

For the three months ended March 31, 2019, Fluidigm tallied $30.1 million in revenues, up from $25.3 million a year ago and besting analysts' consensus estimate of $29.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.